NO912271D0 - Somatostatinpreparater, deres fremstilling og anvendelse. - Google Patents

Somatostatinpreparater, deres fremstilling og anvendelse.

Info

Publication number
NO912271D0
NO912271D0 NO912271A NO912271A NO912271D0 NO 912271 D0 NO912271 D0 NO 912271D0 NO 912271 A NO912271 A NO 912271A NO 912271 A NO912271 A NO 912271A NO 912271 D0 NO912271 D0 NO 912271D0
Authority
NO
Norway
Prior art keywords
somatostatin
preparations
preparation
somatostatin preparations
Prior art date
Application number
NO912271A
Other languages
English (en)
Other versions
NO912271L (no
Inventor
Gerd Fricker
Jacky Vonderscher
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO912271D0 publication Critical patent/NO912271D0/no
Publication of NO912271L publication Critical patent/NO912271L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO91912271A 1990-06-15 1991-06-13 Somatostatinpreparater, deres fremstilling og anvendelse. NO912271L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909013448A GB9013448D0 (en) 1990-06-15 1990-06-15 Pharmaceutical resorption-improved somatostatin compositions,their preparation and use

Publications (2)

Publication Number Publication Date
NO912271D0 true NO912271D0 (no) 1991-06-13
NO912271L NO912271L (no) 1991-12-16

Family

ID=10677720

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912271A NO912271L (no) 1990-06-15 1991-06-13 Somatostatinpreparater, deres fremstilling og anvendelse.

Country Status (21)

Country Link
EP (1) EP0462071B1 (no)
JP (1) JPH04230223A (no)
KR (1) KR920000323A (no)
AU (1) AU7833191A (no)
CA (1) CA2044511A1 (no)
CH (1) CH683069A5 (no)
DE (1) DE4119062A1 (no)
ES (1) ES2067906T3 (no)
FI (1) FI912868A (no)
FR (1) FR2663227B1 (no)
GB (2) GB9013448D0 (no)
HU (1) HUT59007A (no)
IE (1) IE912010A1 (no)
IL (1) IL98477A0 (no)
IT (1) IT1297205B1 (no)
LU (1) LU87952A1 (no)
NO (1) NO912271L (no)
NZ (1) NZ238522A (no)
PT (1) PT97964A (no)
TW (1) TW226332B (no)
ZA (1) ZA914583B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9203769D0 (en) * 1992-02-21 1992-04-08 Sandoz Ltd Improvements in or relating to organic compounds
KR100327563B1 (ko) * 1993-07-30 2002-08-24 데이진 가부시키가이샤 펩티드단백질성약물경기분제조성물
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
CA2406067A1 (en) * 2000-04-19 2001-11-01 Thomas Julius Borody Compositions comprising the combination of a bile acid and a fibrate for use in therapies for hyperlipidaemia-associated disorders
US20030083241A1 (en) * 2001-11-01 2003-05-01 Young Charles W. Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation
DK2275103T3 (da) * 2005-11-21 2014-07-07 Novartis Ag mTor-inhibitorer ved behandling af endokrine tumorer
EP1959982B1 (en) * 2005-12-01 2012-08-08 Flinders Technologies PTY. Ltd. Methods and compositions for preventing and/or treating pancreatitis
CA2963659C (en) 2008-09-17 2020-06-23 Chiasma Inc. Use of oral octreotride compositions
GB0817969D0 (en) * 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
AU2016215350B2 (en) 2015-02-03 2021-11-25 Amryt Endo, Inc. Method of treating diseases
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
NL8701143A (nl) * 1986-05-27 1987-12-16 Sandoz Ag Farmaceutische preparaten.
JPS632932A (ja) * 1986-06-23 1988-01-07 Teijin Ltd 経鼻投与用粉末状組成物
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid

Also Published As

Publication number Publication date
HU911849D0 (en) 1991-12-30
GB9013448D0 (en) 1990-08-08
ITRM910430A1 (it) 1992-12-17
DE4119062A1 (de) 1991-12-19
GB9112509D0 (en) 1991-07-31
GB2244918B (en) 1994-06-15
FI912868A0 (fi) 1991-06-13
CA2044511A1 (en) 1991-12-16
NO912271L (no) 1991-12-16
KR920000323A (ko) 1992-01-29
FI912868A (fi) 1991-12-16
FR2663227A1 (fr) 1991-12-20
ZA914583B (en) 1993-02-24
ES2067906T3 (es) 1995-04-01
JPH04230223A (ja) 1992-08-19
EP0462071B1 (en) 1995-02-01
HUT59007A (en) 1992-04-28
IT1297205B1 (it) 1999-08-03
NZ238522A (en) 1993-10-26
AU7833191A (en) 1992-01-02
PT97964A (pt) 1992-03-31
GB2244918A (en) 1991-12-18
EP0462071A1 (en) 1991-12-18
TW226332B (no) 1994-07-11
FR2663227B1 (fr) 1995-04-28
ITRM910430A0 (it) 1991-06-17
LU87952A1 (fr) 1993-01-15
IE912010A1 (en) 1991-12-18
IL98477A0 (en) 1992-07-15
CH683069A5 (de) 1994-01-14

Similar Documents

Publication Publication Date Title
NO902658D0 (no) N-fenylpyrazolderivater, preparater og anvendelse derav.
NO902661D0 (no) Ribozymer, deres fremstilling og anvendelse.
DK374389D0 (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
NO912058L (no) Bioforlikelige membraner, deres fremstilling og anvendelse
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO912960D0 (no) Polylaktider, deres fremstilling og anvendelse.
NO900469L (no) Piperidinforbindelser, deres fremstilling og anvendelse.
DK462187A (da) Pyridinyl-pyrimidin-derivater, deres fremstilling og anvendelse.
NO940989D0 (no) Triazolkinoksalin-1,4-dioner og deres fremstilling og anvendelse
DK388989D0 (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
NO912271D0 (no) Somatostatinpreparater, deres fremstilling og anvendelse.
DK435289A (da) Piperazindioner, deres fremstilling og anvendelse
NO903978D0 (no) Pyridinyl-kinolonforbindelser, deres fremstilling og bruk.
NO903169D0 (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
NO903096L (no) Termotrope semialifatiske kopolyesteramider og deres fremstilling.
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO164652C (no) Polyfluoralkyltiometyl forbindelser, deres fremstilling og anvendelse.
DK225089A (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
DK73091D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
NO911047D0 (no) Labdaner og fremgangsmaate for deres fremstilling.
NO922992D0 (no) Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse
NO892570D0 (no) Polysilazaner, deres fremstilling og anvendelse.
NO924343D0 (no) Substituerte 1,5 pentandioler og deres fremstilling
DK592389A (da) Penemderivater, deres fremstilling og anvendelse
NO885020D0 (no) Isokinolinderivater, deres fremstilling og anvendelse.